Cell Projects licenses Electroporation Technologies from Queen’s University, Canada
The ground-breaking technology allows DNA, peptides, siRNA and many other molecules to be gently transported into cultured, adherent cells while the cells are still attached to their growing surface. The data shows dramatic improvements of sensitivity and operation over existing methodologies.
Tom Hole MD at Cell Projects says ‘the InSitu technology will enable a greater understanding of specific cellular activities that to date have been difficult to analyze yet are known to be important in further understanding the mechanism of cancer, and other biological problems’.
Most read news
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.